Neonatal Research Institute
Clinical Trial: Treatment of Neonatal Seizures
Clinical trial: Efficacy of intravenous Levetiracetam in the treatment of neonatal seizures (NeoLev2)
Primary investigator: Dr. Richard Haas
Research coordinator: Kathy Arnell
About this trial.
Current treatments for seizures in newborns are not very effective and come with significant side effects. With this study, we hope to improve treatment of neonatal seizures by using Levetiracetam — a promising new treatment. This medicine has been used in oral form in older children for more than a decade, but the IV form has only recently become available.
This study will compare effects of Levetiracetam versus phenobarbital (the traditional treatment for neonatal seizures), obtain essential safety and efficacy data and develop remote EEG monitoring systems that will facilitate rapid seizure detection for quicker treatment.
To learn more about this study, visit ClinicalTrials.gov.
To learn more about the NICU at Sharp Mary Birch, visit Neonatal Intensive Care Unit. For more information about the Neonatal Research Institute or to learn more about our clinical trials, send us an email or call 858-939-4112.